Heresbach D, Devillers A, Rabot A, Moisan A, Malledant Y, Bourguet P, Bretagne J F, Gosselin M
Service d'Hépatogastroentérologie et d'Assistance Nutritive, CHRU Pontchaillou, Rennes, France.
Pancreas. 1996 May;12(4):381-7. doi: 10.1097/00006676-199605000-00010.
Clinical and laboratory data or imaging results cannot provide a positive diagnosis of septic complications of pancreatic and peripancreatic necrosis in patients with acute pancreatitis. Confirmation can be obtained only after percutaneous computed tomography (CT)-guided aspiration of the necrotic tissues or fluid collection; although the important role of 99Tc(m)-HMPAO-labeled granulocyte scintigraphy has been recently emphasized. The aim of this study was to determine the sensitivity and specificity of 99m-technetium-hexamethylpropyleneamine oxime (99Tc(m)-HMPAO)- or 111In-oxine-labeled granulocyte scintigraphy for the diagnosis of infection in pancreatic or peripancreatic necrosis to define the ideal label for diagnosis. Thirty-six scintigraphic examinations were performed in 34 consecutive patients (mean age, 58 +/- 2 years) 20 +/- 2 days after the onset of acute pancreatitis (Balthazar classes A-C, n = 7; classes D and E, n = 29). The scintigraphic study included scintigraphic tomography and static acquisition 1 and 3 h, respectively, after reinjection of the autologous 99Tc(m)-labeled granulocytes and static images 3-4 and 24 h after the simultaneous reinjection of 111In-oxine-labeled autologous granulocytes. The diagnosis of infected pancreatic or peripancreatic necrosis was confirmed with percutaneous CT-guided aspiration (14 positive aspirates among 20 performed) and sterile necrosis after negative aspiration (6 negative aspirates) or after a 6 +/- 1-month follow-up free of clinical or biological signs of ongoing sepsis. The sensitivity and specificity were 86 and 73%, respectively, for scintigraphic tomography, 100 and 55% for 3-h 111In images, 93 and 68% for 3-4-h 111In images, and 100 and 64% for 24-h 111In images. The fall in splenic activity between the 3-4 and the 24-h 111In images was 26 +/- 3% in patients with septic pancreatic and peripancreatic necrosis (n = 14) and 16 +/- 3% in those with sterile necrosis (n = 22) (p < 0.01). Labeled granulocyte scintigraphy was thus shown to be an effective tool for the diagnosis of infection in pancreatic and/or peripancreatic necrosis due to acute pancreatitis, especially when the scintiscans are performed early after injection of 99Tc(m) or when the fall in splenic activity over the 24 h following reinjection of 111In is measured in particularly difficult cases. These promising preliminary results should be confirmed by a prospective study.
临床和实验室数据或影像学结果无法对急性胰腺炎患者胰腺及胰周坏死的感染性并发症作出肯定诊断。只有在经皮计算机断层扫描(CT)引导下对坏死组织或积液进行穿刺抽吸后才能确诊;尽管最近已强调了99锝(m)-六甲基丙烯胺肟(99Tc(m)-HMPAO)标记的粒细胞闪烁显像的重要作用。本研究的目的是确定99锝-六甲基丙烯胺肟(99Tc(m)-HMPAO)或111铟-奥克辛标记的粒细胞闪烁显像对胰腺或胰周坏死感染诊断的敏感性和特异性,以确定理想的诊断标记物。在34例连续患者(平均年龄58±2岁)急性胰腺炎发病后20±2天进行了36次闪烁显像检查(巴尔萨泽分级A-C级,n = 7;D级和E级,n = 29)。闪烁显像研究包括在重新注射自体99Tc(m)标记的粒细胞后分别于1小时和3小时进行闪烁断层扫描和静态采集,以及在同时重新注射111铟-奥克辛标记的自体粒细胞后3 - 4小时和24小时进行静态图像采集。经皮CT引导下穿刺抽吸确诊为感染性胰腺或胰周坏死(20次穿刺中有14次阳性抽吸物),阴性抽吸后为无菌性坏死(6次阴性抽吸物)或在6±1个月的随访中无持续脓毒症的临床或生物学迹象。闪烁断层扫描的敏感性和特异性分别为86%和73%,111铟标记3小时图像的敏感性和特异性分别为100%和55%,111铟标记3 - 4小时图像的敏感性和特异性分别为93%和68%,111铟标记24小时图像的敏感性和特异性分别为100%和64%。感染性胰腺和胰周坏死患者(n = 14)111铟标记3 - 4小时图像与24小时图像之间脾脏活性下降为26±3%,无菌性坏死患者(n = 22)为16±3%(p < 0.01)。因此,标记粒细胞闪烁显像被证明是诊断急性胰腺炎所致胰腺和/或胰周坏死感染的有效工具,特别是在注射99Tc(m)后早期进行闪烁扫描时,或在特别困难的病例中测量重新注射111铟后24小时内脾脏活性下降时。这些有前景的初步结果应通过前瞻性研究加以证实。